Figure 2
Cumulative curves of the OCT-derived MLA (mm2) differences between post-PCI and 6 M (A) and between post-PCI and 12 M (B). Pie charts show the percentage of each tissue type as assessed at baseline before the implantation of the DREAMS 3G device in each of the terciles. In both panels, the patients who experience larger luminal loss (larger difference in MLAs = the tercile 3) had a larger percentage of fibrous tissue at baseline.

Cumulative curves of the OCT-derived MLA (mm2) differences between post-PCI and 6 M (A) and between post-PCI and 12 M (B). Pie charts show the percentage of each tissue type as assessed at baseline before the implantation of the DREAMS 3G device in each of the terciles. In both panels, the patients who experience larger luminal loss (larger difference in MLAs = the tercile 3) had a larger percentage of fibrous tissue at baseline.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close